EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comparison of no-reflow phenomenon in patients with ST-segment- elevation myocardial infarction undergoing primary PCI vs. pharmaco-invasive strategy: a single-centre study

Ayush Shukla, Awadhesh Kumar Yadav, Akhil Kumar Sharma, Gaurav Kumar Chaudhary, Umesh Chandra Tripathi, Sharad Chandra, Rishi Sethi, Akshyaya Pradhan, Pravesh Vishwakarma, Monika Bhandari, Abhishek Singh

Frontiers in Cardiovascular Medicine · 13.08.2026 · 13

DOI: 10.3389/fcvm.2026.1899340 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 13.08.2026. Verfasst von Ayush Shukla und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, King George's Medical University, Lucknow, India. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The no-reflow phenomenon after percutaneous coronary intervention (PCI) in ST-segment elevation myocardial infarction (STEMI) represents a major barrier to successful reperfusion, leading to adverse outcomes despite epicardial vessel patency. Comparative evidence regarding its incidence and clinical consequences between primary PCI and pharmaco-invasive PCI remains scarce.

Aim

The study aimed to compare the incidence of the no-reflow phenomenon in patients undergoing pharmaco-invasive PCI versus primary PCI, and to evaluate the short-term clinical outcomes of patients with no-reflow at three months post-procedure.

Methods

In this prospective, single centre, observational study, STEMI patients presenting within 24 h of symptom onset were enrolled at a tertiary care centre. Patients experiencing no-reflow were categorized into Group A (primary PCI; n = 92) and Group B (pharmaco-invasive PCI; n = 192). Baseline demographics, comorbidities, angiographic characteristics, and outcomes were analysed. The primary outcome was the incidence of major adverse cardiac events at three months.

Results

Among 857 patients undergoing primary PCI and 2,976 undergoing pharmaco-invasive PCI, the incidence of no-reflow was significantly higher in the primary PCI group (10.7% vs. 6.5%). Patients in Group A were older (58.9 ± 13.6 vs. 54.4 ± 11.4 years; P = 0.004) and more frequently diabetic (55.4% vs. 41.6%; P = 0.029), whereas hypertension was more prevalent in Group B (42.7% vs. 13.0%; P < 0.001). Baseline TIMI 0 flow was more common in Group A (79.3% vs. 24.5%; P < 0.001). After PCI, final TIMI 3 flow rates were comparable (85.9% vs. 89.6%; P = 0.361). In-hospital complications and three-month outcomes were similar between two groups: death (4.3% vs. 5.2%), revascularization (4.3% vs. 4.7%), and rehospitalization (5.4% vs. 3.1%) (all P > 0.05).

Conclusion

No-reflow was more frequent after primary PCI, particularly in older, diabetic, and late-presenting patients with baseline TIMI 0 flow. Both reperfusion strategies achieved comparable short-term clinical outcomes in no-reflow patients. Pharmaco-invasive PCI may mitigate the risk of no-reflow in selected STEMI patients while maintaining equivalent early prognosis.

Schlagwörter

Stichwörter der Autor:innen

Cardiovascular dieaseST-elevation myocardial infarctionno-reflow phenomenonpercutaneous coronary interventionpharmaco-invasive

Autor:innen und Institutionen

  • Department of Cardiology, King George's Medical University, Lucknow, India.

Zitieren

APA

Shukla, A., Yadav, A. K., Sharma, A. K., Chaudhary, G. K., Tripathi, U. C., Chandra, S., Sethi, R., Pradhan, A., Vishwakarma, P., Bhandari, M., & Singh, A. (2026). Comparison of no-reflow phenomenon in patients with ST-segment- elevation myocardial infarction undergoing primary PCI vs. pharmaco-invasive strategy: a single-centre study. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1899340

Vancouver

Shukla A, Yadav AK, Sharma AK, Chaudhary GK, Tripathi UC, Chandra S, et al. Comparison of no-reflow phenomenon in patients with ST-segment- elevation myocardial infarction undergoing primary PCI vs. pharmaco-invasive strategy: a single-centre study. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1899340

BibTeX
@article{Shukla2026,
  author = {Shukla, Ayush and Yadav, Awadhesh Kumar and Sharma, Akhil Kumar and Chaudhary, Gaurav Kumar and Tripathi, Umesh Chandra and Chandra, Sharad and Sethi, Rishi and Pradhan, Akshyaya and Vishwakarma, Pravesh and Bhandari, Monika and Singh, Abhishek},
  title = {Comparison of no-reflow phenomenon in patients with ST-segment- elevation myocardial infarction undergoing primary PCI vs. pharmaco-invasive strategy: a single-centre study},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fcvm.2026.1899340}
}
Kostenlos starten →